Related Experiment Video
Updated: Apr 25, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Epidemiology of tuberculosis].
M Mjid1, J Cherif1, N Ben Salah2
1Unité de recherche 12SP06, service de pneumologie allergologie, faculté de médecine de Tunis, université de Tunis El-Manar, CHU La Rabta, 1007 Tunis, Tunisie.
Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a major global health threat, causing over a million deaths annually. Addressing TB requires targeted screening and diagnosis, especially in vulnerable populations and high-incidence regions.
Area of Science:
- Infectious Diseases
- Public Health Epidemiology
- Microbiology
Context:
- Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a leading global cause of death, with millions of new cases and over a million deaths annually.
- Co-infection with human immunodeficiency virus (HIV) and the rise of drug-resistant strains exacerbate the TB burden.
- Significant regional disparities exist, with Africa experiencing the highest morbidity and mortality rates, and Eastern Europe facing increasing drug-resistant TB.
Purpose:
- To highlight the persistent global public health challenge posed by tuberculosis.
- To underscore the impact of co-infections and drug resistance on TB incidence and mortality.
- To emphasize the need for targeted screening, diagnosis, and monitoring in vulnerable populations and specific high-risk regions.
Summary:
- Mycobacterium tuberculosis causes tuberculosis (TB), a significant global health issue with high annual mortality.
- Despite incidence decreases, morbidity and mortality persist due to factors like HIV co-infection and drug-resistant TB.
- Regional variations in TB prevalence, particularly in Africa and Eastern Europe, necessitate tailored public health interventions.
Impact:
- The ongoing threat of tuberculosis underscores the critical need for continued global health initiatives and research.
- Understanding regional disparities and contributing factors like drug resistance is crucial for effective TB control strategies.
- The Stop TB program aims to reduce the global burden of TB, aligning with international health targets.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Introduction to Epidemiology

